Cargando…
Effects of metformin on tumor hypoxia and radiotherapy efficacy: a [(18)F]HX4 PET imaging study in colorectal cancer xenografts
BACKGROUND: In a colorectal cancer xenograft model, we investigated the therapeutic effect of metformin on tumor hypoxia with [(18)F]flortanidazole ([(18)F]HX4) small-animal positron emission tomography (μPET). We also assessed the additive effect of metformin on long-term radiotherapy outcome and w...
Autores principales: | De Bruycker, Sven, Vangestel, Christel, Staelens, Steven, wyffels, Leonie, Detrez, Jan, Verschuuren, Marlies, De Vos, Winnok H., Pauwels, Patrick, Van den Wyngaert, Tim, Stroobants, Sigrid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6677842/ https://www.ncbi.nlm.nih.gov/pubmed/31375940 http://dx.doi.org/10.1186/s13550-019-0543-4 |
Ejemplares similares
-
How to Modulate Tumor Hypoxia for Preclinical In Vivo Imaging Research
por: De Bruycker, Sven, et al.
Publicado: (2018) -
Early Changes in [(18)F]FDG Uptake as a Readout for PI3K/Akt/mTOR Targeted Drugs in HER-2-Positive Cancer Xenografts
por: Dockx, Yanina, et al.
Publicado: (2021) -
Characterization of [(99m)Tc]Duramycin as a SPECT Imaging Agent for Early Assessment of Tumor Apoptosis
por: Elvas, Filipe, et al.
Publicado: (2015) -
First-in-human study of a novel cell death tracer [(99m)Tc]Tc-Duramycin: safety, biodistribution and radiation dosimetry in healthy volunteers
por: Metelerkamp Cappenberg, Taco, et al.
Publicado: (2023) -
Preclinical Evaluation of a Novel (18)F-Labeled
dTCO-Amide Derivative for Bioorthogonal Pretargeted Positron Emission
Tomography Imaging
por: Ruivo, Eduardo, et al.
Publicado: (2020)